Skip to content
DraconiticResearch
Search Sources API
210,089 studies31 sourcesUpdated 48 min ago
Peer-reviewedCC BY-NC-ND 4.0The Australasian Journal of Dermatology

Dupilumab‐Associated Erythema Multiforme‐Like Eruption With Lichenoid Histology in a Paediatric Patient: A Case Report

4 affiliations
  1. 1Sydney Medical School, Faculty of Medicine and Health The University of Sydney Sydney New South Wales Australia
  2. 2Department of Dermatology The Children's Hospital at Westmead Sydney New South Wales Australia
  3. 3Hills Allergy and Specialists Clinic Sydney New South Wales Australia
  4. 4Department of Histopathology The Children's Hospital at Westmead Sydney New South Wales Australia

Abstract

Dupilumab‐associated erythema multiforme and lichenoid eruptions have been previously reported as rare dermatological adverse events. We present an atypical paediatric case of a dupilumab‐associated erythema multiforme‐like eruption in a 5‐year‐old male eczema patient, who developed erythematous targetoid papules and plaques over the upper and lower limbs, with a biopsy suggestive of a lichenoid interface reaction. Dupilumab was discontinued, and the side effect was managed with topical corticosteroids, leading to resolution of the lesions with mild residual post‐inflammatory skin hyperpigmentation.

Related

  1. Sustained Platelet Improvement Temporally Associated with Dupilumab in Chronic Immune Thrombocytopenia: A Case Study
    Xinyu Xu, Nicholas R. Burwick, Sarah K. Baxter +3
    Journal of clinical medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Osimertinib induced lichenoid dermatitis successfully treated with acitretin.
    Alim Osman, Klaus J Busam, Gregory J Riely +1
    JAAD case reportsPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMCPMC
  3. Preoperative Systemic Inflammatory Indices (SII, SIRI and PIV) Associated with Adverse Histology and 12-Month Recurrence After Transurethral Resection of Non-Muscle-Invasive Bladder Cancer
    Dragoș Florin Vasile, Mihnea Meșină, George G. Mitroi +5
    Journal of Clinical MedicinePeer-reviewedCC BY 4.0General medicineCrossref
  4. Lichenoid and Granulomatous Stomatitis: Three Additional Cases and Detailed Immunohistochemical Analysis
    Mariana Paravani Palaçon, Karina Kendelhy Santos, Karina Helen Martins +10
    Journal of Cutaneous PathologyPeer-reviewedCC BY 4.0Full textGeneral medicinePMC
  5. Microbiological aetiology of paediatric ventilator-associated pneumonia and risk factors for carbapenem-resistant acinetobacter and Pseudomonas in a tertiary-care hospital in Thailand.
    Nicharee Chruakanchana, Napaporn Chantasrisawad, Wirada Horapong +1
    Infection prevention in practicePeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
BibTeX
@article{kim2026dupilumabassociated,
  title = {{Dupilumab‐Associated Erythema Multiforme‐Like Eruption With Lichenoid Histology in a Paediatric Patient: A Case Report}},
  author = {Paul Sun Woo Kim and Jacqueline Tu and Kelvin Truong and Gloria Fong and William Luu and Narinder Kaur and Miriam Fewtrell and Li‐Chuen Wong},
  journal = {The Australasian Journal of Dermatology},
  year = {2026},
  month = jul,
  doi = {10.1111/ajd.70175},
  url = {https://doi.org/10.1111/ajd.70175},
  note = {CC BY-NC-ND 4.0},
}
RIS
TY  - JOUR
TI  - Dupilumab‐Associated Erythema Multiforme‐Like Eruption With Lichenoid Histology in a Paediatric Patient: A Case Report
AU  - Paul Sun Woo Kim
AU  - Jacqueline Tu
AU  - Kelvin Truong
AU  - Gloria Fong
AU  - William Luu
AU  - Narinder Kaur
AU  - Miriam Fewtrell
AU  - Li‐Chuen Wong
PY  - 2026
DA  - 2026/07/07
JO  - The Australasian Journal of Dermatology
DO  - 10.1111/ajd.70175
UR  - https://doi.org/10.1111/ajd.70175
AB  - Dupilumab‐associated erythema multiforme and lichenoid eruptions have been previously reported as rare dermatological adverse events. We present an atypical paediatric case of a dupilumab‐associated erythema multiforme‐like eruption in a 5‐year‐old male eczema patient, who developed erythematous targetoid papules and plaques over the upper and lower limbs, with a biopsy suggestive of a lichenoid interface reaction. Dupilumab was discontinued, and the side effect was managed with topical corticosteroids, leading to resolution of the lesions with mild residual post‐inflammatory skin hyperpigmentation.
SN  - 0004-8380
SN  - 1440-0960
ER  -